文献速递细菌感染、耐药与抗菌药物医院感染防控

耐药微生物所致医院获得性感染对发病率、死亡率和住院时长的影响

Impact on Morbidity, Mortality, and Length of Stay of Hospital-Acquired Infections by Resistant Microorganisms.
PubMed 文献 · Clin Infect Dis · 2017-01-01

该回顾性队列研究纳入324例耐药菌感染病例和676例敏感菌感染对照,评估耐药菌医院获得性感染对死亡率、再入院和住院时长的影响。结果显示耐药菌感染增加全因死亡、感染后30天死亡和再入院风险,部分耐药菌增加急诊就诊,但不影响住院时长及其他发病率指标。

要点

  • 耐药菌医院获得性感染增加全因死亡风险(HR 1.7)和感染后30天死亡风险(HR 1.77)。
  • 耐药菌感染患者再入院风险升高(OR 2.17)。
  • MRSA和大肠埃希菌耐药感染与急诊就诊增加相关,但耐药菌感染不延长住院时长。

核心结论

  • 耐药菌所致医院感染较敏感菌感染增加死亡、再入院及部分急诊就诊风险。
  • 耐药菌感染不增加住院时长、ICU入住、手术需求或诊断检查次数。

研究设计与样本

  • 回顾性队列研究,纳入324例耐药菌感染病例和676例敏感菌感染对照。
  • 研究对象为≥18岁成人,感染部位为呼吸道、泌尿道、血流或手术部位。

主要发现

  • 全因住院死亡风险在耐药菌感染组更高(HR 1.7;95%CI 1.25-2.32)。
  • 感染后30天死亡风险在耐药菌感染组更高(HR 1.77;95%CI 1.29-2.44)。
  • 再入院概率在耐药菌感染组更高(OR 2.17;95%CI 1.36-3.46)。
  • 急诊就诊仅在MRSA感染(OR 2.80;95%CI 1.65-4.74)和耐药大肠埃希菌感染(OR 2.28;95%CI 1.32-3.96)中显著升高。
  • 耐药菌感染与其他结局(住院时长、ICU入住、手术、诊断检查次数)无显著关联。

临床怎么用

  • 对耐药菌医院感染患者应关注死亡和再入院风险,加强出院后随访。
  • MRSA和耐药大肠埃希菌感染患者需警惕急诊就诊需求。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Infections by multidrug-resistant organisms (MDROs) are a global threat and are particularly common in hospitals. This study was performed to assess the impact of hospital-acquired infections caused by MDROs on morbidity, mortality, and length of hospital stay. METHODS: This was a retrospective cohort study. A sample of adults aged ≥18 years with a respiratory, urinary, bloodstream, or surgical site infection caused by a multidrug-resistant (cases) or -sensitive (controls) microorganism was selected. Measurements included hospital mortality from all causes (total and 30 days after infection), length of stay (LOS), and 5 indicators of morbidity: intensive care or surgery admissions, number of diagnostic tests after infection, and hospital readmissions or visits to the emergency department within 30 days of discharge. RESULTS: The sample was composed of 324 cases and 676 control patients. Risk of hospital mortality from all causes (hazard ratio [HR], 1.7; 95% confidence interval [CI], 1.25-2.32) and 30 day-mortality after infection (HR, 1.77; 95% CI, 1.29-2.44) were higher in patients with an MDRO infection. Probability of readmission was also higher (odds ratio [OR], 2.17; 95% CI, 1.36-3.46) in the case group. Emergency department visits were only significantly higher in methicillin-resistant Staphylococcus aureus (OR, 2.80; 95% CI, 1.65-4.74) and in Escherichia coli-resistant infections (OR, 2.28; 95% CI, 1.32-3.96). Infections by MDRO were not associated with any other outcome. CONCLUSIONS: Hospital infections caused by MDROs increase mortality, readmissions, and in some cases, visits to the emergency department compared with those produced by susceptible strains. They do not appear to influence LOS nor the need for hospital admission, intensive care, surgery, or diagnostic tests.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Barrasa-Villar JI, Aibar-Remón C, Prieto-Andrés P, et al. Impact on Morbidity, Mortality, and Length of Stay of Hospital-Acquired Infections by Resistant Microorganisms. Clin Infect Dis. 2017. PMID: 28472416. doi:10.1093/cid/cix411

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。